stopping and restarting semaglutide Your Weight Loss Journey? Why "Stocking Up" at a High Dose Can Be a Dangerous Doctors explain what really happens
Description
A 2024 study found that 69% of U.S
Competing interests KS declares nothing to disclose
This can be both a serious and common side effect
One major error is assuming that stronger medication means you can ignore the basics of health
Patients taking GLP-1 medications with insulin or sulfonylureas have an increased risk of hypoglycemia and should discuss timing of all medications with their healthcare provider to minimize this risk
While lower cost is appealing, safety, proper dosing, and medical supervision are critical
